Cash pulled forward: buyers are funding the company's next stage in advance, and the money keeps arriving
The model's full reasoning — Q2 2018 call → NOWe need to determine if the company is receiving advance payments or binding commitments from customers before delivery, and if management describes this as growing and financing future growth. The transcript is about Essex Property Trust, a real estate investment trust (REIT) that owns apartment properties. The business model is renting apartments. Typically, rent is paid monthly in advance, but that's standard. The question is about advance funding from customers (tenants) that is growing and financing next stage. The transcript discusses occupancy, rent growth, leasing, etc. There is no mention of deposits, prepayments, or tenants paying ahead in a way that is growing and financing development. The company's development is funded by dispositions and debt, not by tenant prepayments. The transcript mentions "pre-leasing" for future phases, but that's just leasing ahead of construction, not necessarily paying in advance. Pre-leasing means signing leases before completion, but rent is paid when occupancy begins. No mention of deposits or advance rent. The company's revenue is from rents, which are earned monthly. No indication of advance funding from customers. The only advance commitments might be from preferred equity investments, but those are investments, not customer prepayments. The question is about counterparties paying before receiving goods/services. In this case, tenants pay rent for the period they occupy, which is standard. No growth in advance payments described. So answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| PDS | Precision Drilling Corporation | Q1 2024 | 2024-04-25 | B |
| NBTX | Nanobiotix S.A. | Q2 2023 | 2023-09-27 | D |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| EEX | Emerald Holding, Inc. | Q2 2021 | 2021-08-01 | C+ |
| LIND | Lindblad Expeditions Holdings, Inc. | Q2 2017 | 2017-08-06 | C |
| PTC | PTC Inc. | Q3 2017 | 2017-07-19 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
SYM · Q3 2022 → YESThe question is about whether management describes that money or binding financial commitment is arriving at the company ahead of the work it will pay for, and they treat this as growing and financing...YES Management describes a "very significant cost float" from "strong deferred revenue on the balance sheet" that helps fund the company's growth strategy, along with improved payable terms. This ties directly to the $11.3 billion backlog and the ability to invest aggressively in scaling deployments, inventory, and operations ahead of full revenue recognition.
IONS · Q1 2017 → YESThe question is about whether management describes that money or binding financial commitment is arriving at the company ahead of the work it will pay for, and they treat this as growing and financing...YES Management describes exactly this pattern: Novartis delivered $175 million (including $75 million upfront plus $100 million equity at a premium) before the Phase IIb studies are conducted, and Bayer paid $75 million to advance IONIS-FXIRx and IONIS-FXI-LRx before full development work is complete 65-plus percent of which was already recognized in Q1.
LIND · Q2 2017 → YESThe question is about whether management describes that money or binding financial commitment is arriving at the company ahead of the work it will pay for, and if they treat this as growing and financ...YES The transcript shows management describing a clear pattern of advance bookings and forward reservations that are growing (nearly 40% year-to-date, up nearly 50% in July, highest booking day ever) and that directly de-risk and finance the next stage of growth.